Curtiss-Wright Corporation (CW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Curtiss-Wright Corporation on November 21, 2025, reporting events that occurred on November 20, 2025. The filing details a new share repurchase authorization and the adoption of Rule 10b5-1 trading plans.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital allocation activities.
- Share Repurchase Authorization: The Board authorized an additional $416 million for common stock repurchases.
- Total Available Authorization: $550 million (comprising the new $416 million plus $134 million remaining from prior authorizations).
- Trading Plan 1: $60 million to be executed equally throughout calendar year 2026.
- Trading Plan 2: Up to $100 million with a price limit; execution is not guaranteed.
Material Changes
The primary material change is the expansion of the Company's share repurchase program. The total available capital for buybacks increased to $550 million. Additionally, the Company formally adopted two Rule 10b5-1 trading plans effective January 2, 2026, to facilitate these purchases while managing insider trading restrictions.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use repurchases to offset dilution from employee equity-based compensation plans and may make discretionary, opportunistic purchases. The authorization has no expiration date and can be amended or terminated at any time.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Risks include stock price volatility, changes in market conditions, and regulatory requirements. The Company explicitly states it does not undertake to update forward-looking statements.
Investor Verification Checklist
- Verify the total remaining authorization of $550 million against subsequent Form 10-Q filings to track actual repurchase activity.
- Monitor the execution of the $60 million fixed trading plan and the conditional $100 million plan during 2026.
- Review the referenced press release (Exhibit 99.1) for any additional context on the strategic rationale.
- Check the Company's 2024 Form 10-K and Q3 2025 Form 10-Q for broader risk factors and financial health context not included in this 8-K.